Literature DB >> 868891

Absolute bioavailability of oral theophylline.

L Hendeles, M Weinberger, L Bighley.   

Abstract

The absolute bioavailability of theophylline was investigated by comparing the areas under concentration-time curves for intravenous theophylline with a plain uncoated anhydrous theophylline tablet and a theophylline solution. Twenty asthmatic adults received approximately 7.5 mg/kg theophylline intravenously over 30 minutes; either seven days before or after the i.v. dose, 10 of these patients received tablets and the remainder solution in a similar dose. Blood samples were obtained at 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes and then every two hours for at least 12 hours. Theophylline concentration was measured in serum by high-pressure cation exchange chromatography. The fraction of the dose absorbed averaged 0.96 +/- 0.03 for the tablet while the value for the solution was 0.99 +/- 0.02. The time of peak absorption averaged 2 +/- 0.3 hours for the tablets and 1.4 +/- 0.3 hours for the solution. The maximum serum concentration attained was 15.3 +/- 0.7 microng/ml after a dose of 7.6 +/- 0.4 mg/kg of the tablet, and 14.6 +/- 0.6 microng/ml after a dose of 7.3 +/- 0.2 mg/kg of the solution. Absorption of the tested theophylline tablets and solution approached 100% of the available drug.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 868891

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  28 in total

1.  Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers.

Authors:  Zeynep S Teksin; Paul R Seo; James E Polli
Journal:  AAPS J       Date:  2010-03-12       Impact factor: 4.009

2.  Advocating for patients through clinical research.

Authors:  Leslie Hendeles
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

3.  The population pharmacokinetics of theophylline in neonates and young infants.

Authors:  E S Moore; R G Faix; R C Banagale; T H Grasela
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 4.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

5.  Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.

Authors:  L N Sansom; R W Milne; D Cooper
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

6.  In vivo/in vitro correlation of experimental sustained-release theophylline formulations.

Authors:  K H Yuen; A A Desmukh; J M Newton
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

Review 7.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

9.  Longitudinal effects of pregnancy on the pharmacokinetics of theophylline.

Authors:  M J Gardner; M Schatz; L Cousins; R Zeiger; E Middleton; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Prolonged storage of aminophylline suppositories. The impact on physical parameters and bioavailability.

Authors:  J J Tukker; C J De Blaey
Journal:  Pharm Weekbl Sci       Date:  1984-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.